NZ551726A - Treatment or prevention of surface conditions in animals using boryloxypyridylmethanones - Google Patents

Treatment or prevention of surface conditions in animals using boryloxypyridylmethanones

Info

Publication number
NZ551726A
NZ551726A NZ551726A NZ55172605A NZ551726A NZ 551726 A NZ551726 A NZ 551726A NZ 551726 A NZ551726 A NZ 551726A NZ 55172605 A NZ55172605 A NZ 55172605A NZ 551726 A NZ551726 A NZ 551726A
Authority
NZ
New Zealand
Prior art keywords
alkyl
aryl
optionally substituted
substituted
chloro
Prior art date
Application number
NZ551726A
Other languages
English (en)
Inventor
David Perry
Kirk R Maples
Carolyn Bellinger-Kawahara
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of NZ551726A publication Critical patent/NZ551726A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ551726A 2004-06-14 2005-06-14 Treatment or prevention of surface conditions in animals using boryloxypyridylmethanones NZ551726A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57942104P 2004-06-14 2004-06-14
PCT/US2005/021165 WO2005123094A2 (en) 2004-06-14 2005-06-14 Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones

Publications (1)

Publication Number Publication Date
NZ551726A true NZ551726A (en) 2010-09-30

Family

ID=35276660

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ551726A NZ551726A (en) 2004-06-14 2005-06-14 Treatment or prevention of surface conditions in animals using boryloxypyridylmethanones

Country Status (18)

Country Link
US (1) US7652000B2 (https=)
EP (1) EP1765358B1 (https=)
JP (1) JP2008502696A (https=)
KR (1) KR20070043776A (https=)
CN (1) CN1972695A (https=)
AR (1) AR049915A1 (https=)
AT (1) ATE499105T1 (https=)
AU (1) AU2005254095B2 (https=)
BR (1) BRPI0512054A (https=)
CA (1) CA2570477A1 (https=)
DE (1) DE602005026524D1 (https=)
IL (1) IL179616A0 (https=)
MX (1) MXPA06014416A (https=)
NZ (1) NZ551726A (https=)
RU (1) RU2007101309A (https=)
TW (1) TW200612966A (https=)
WO (1) WO2005123094A2 (https=)
ZA (1) ZA200610353B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2343304B1 (en) 2005-02-16 2015-06-10 Anacor Pharmaceuticals, Inc. Biocidal boronophthalide compounds
WO2006102604A2 (en) * 2005-03-24 2006-09-28 Anacor Pharmaceuticals, Inc. Topical formulations of borinic acid antibodies and their methods of use
CA2635840A1 (en) * 2005-12-28 2007-07-12 Anacor Pharmaceuticals, Inc. Process for manufacturing picolinate borinic esters
KR20080110984A (ko) 2005-12-30 2008-12-22 아나코르 파마슈티칼스 인코포레이티드 보론함유 소분자
PT1988779E (pt) 2006-02-16 2015-09-04 Anacor Pharmaceuticals Inc Moléculas pequenas contendo boro como agentes antiinflamatórios
RU2008152367A (ru) * 2006-06-12 2010-07-20 Анакор Фармасьютикалз, Инк. (Us) Соединения для лечения периодонтального заболевания
KR20150065941A (ko) 2008-03-06 2015-06-15 아나코르 파마슈티칼스 인코포레이티드 소염제로써 붕소가 함유된 소분자
WO2010018836A2 (ja) * 2008-08-11 2010-02-18 独立行政法人科学技術振興機構 ポリグルタミン凝集阻害剤
WO2010028005A1 (en) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
EP2348863A4 (en) 2008-09-04 2012-03-07 Anacor Pharmaceuticals Inc BORN SMALL MOLECULES
WO2010045503A1 (en) * 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
TW201109022A (en) 2009-06-03 2011-03-16 Colgate Palmolive Co Borinic compositions
AP4039A (en) 2009-08-14 2017-02-28 Daitao Chen Boron-containing small molecules as antiprotozoal agents
WO2011049971A1 (en) 2009-10-20 2011-04-28 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
WO2011060196A1 (en) 2009-11-11 2011-05-19 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2011094450A1 (en) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Boron-containing small molecules
AP2012006482A0 (en) 2010-03-19 2012-10-31 Anacor Pharmacueticals Inc Boron-containing small molecules as anti-protozoalagent
SI3251678T1 (sl) 2010-09-07 2022-01-31 Anacor Pharmaceuticals, Inc. Derivati benzoksaborola za zdravljenje bakterijskih okužb
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
MA38319A1 (fr) 2013-01-30 2016-08-31 Dow Agrosciences Llc Utilisation des benzoxaboroles à titre d'agents antimicrobiens volatils sur les viandes, les plantes, ou des parties de plantes
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
KR101756785B1 (ko) * 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
WO2016207411A1 (en) * 2015-06-24 2016-12-29 Oriel Seasalt Company Limited A highly concentrated seawater mineral extract and uses thereof
RS64770B1 (sr) 2016-03-07 2023-11-30 Agrofresh Inc Sinergistički postupci upotrebe jedinjenja benzoksaborola i gasova za prezerviranje kao antimikrobnih agenasa za useve
MA52337A (fr) 2017-03-01 2021-03-03 Anacor Pharmaceuticals Inc Nouveaux analogues d'oxaborole et utilisations de ces derniers
EP4204012A1 (en) 2020-08-31 2023-07-05 Pfizer Inc. Methods of protecting rna

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790627A (fr) * 1971-10-27 1973-04-27 Lilly Co Eli L'antibiotique a477 et son procede de preparation
US5348947A (en) 1993-05-07 1994-09-20 American Cyanamid Company Diarylboron ester and thioester fungicidal agents
US6123925A (en) * 1998-07-27 2000-09-26 Healthshield Technologies L.L.C. Antibiotic toothpaste
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
JP2003514023A (ja) 1999-11-19 2003-04-15 トツプジーン・インコーポレイテツド 抗炎症剤としてのホウ素化合物および複合体
EP1980564A1 (en) * 2002-12-18 2008-10-15 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use

Also Published As

Publication number Publication date
AU2005254095A1 (en) 2005-12-29
CN1972695A (zh) 2007-05-30
DE602005026524D1 (de) 2011-04-07
JP2008502696A (ja) 2008-01-31
IL179616A0 (en) 2007-05-15
WO2005123094A2 (en) 2005-12-29
ATE499105T1 (de) 2011-03-15
WO2005123094A3 (en) 2006-02-23
AR049915A1 (es) 2006-09-13
EP1765358A2 (en) 2007-03-28
EP1765358B1 (en) 2011-02-23
TW200612966A (en) 2006-05-01
US20060009422A1 (en) 2006-01-12
AU2005254095B2 (en) 2010-06-03
US7652000B2 (en) 2010-01-26
CA2570477A1 (en) 2005-12-29
KR20070043776A (ko) 2007-04-25
MXPA06014416A (es) 2007-03-08
BRPI0512054A (pt) 2008-02-06
RU2007101309A (ru) 2008-07-20
ZA200610353B (en) 2010-07-28

Similar Documents

Publication Publication Date Title
NZ551726A (en) Treatment or prevention of surface conditions in animals using boryloxypyridylmethanones
RU2508113C2 (ru) Борсодержащие малые молекулы в качестве противовоспалительных средств
US12171756B2 (en) NLRP3 modulators
IL185080A (en) Boron-containing small molecules, pharmaceutical formulations comprising them and use thereof in the preparation of medicaments for treating infections
US20220098188A1 (en) Small molecule pyrin-domain targeted nlrp3 inflammasome inhibitors
EA024197B1 (ru) Соединения, ингибирующие металлоферменты
IL257559A (en) Hydroxytriazine compound and its medical use
PT1768666E (pt) Novas utilizações de compostos de porfirina
US20220016075A1 (en) Methods for the treatment of mycobacterium infections
JP2022524118A (ja) アビバクタム誘導体の結晶形
IL296956A (en) Preparations and methods for the treatment of inflammatory bowel disease using a ccr9 inhibitor and anti-il-23 blocking antibodies
US20240398800A1 (en) Compounds for targeted degradation of taf1
IL273242B2 (en) 6-chloro-3-(4,2-dichloro-5-methoxyphenyl)-2-mercapto-7-methoxyquinazolin-4 (3h)-one and derivative compounds, preparations containing them and their uses
JP6872195B2 (ja) コラーゲン産生抑制剤
EP4107145B1 (en) Pyrazole-indole conjugates for photodynamic treatment of cancer and bacterial infections
US11072587B2 (en) Administration of aurora kinase inhibitors for anti-malarial therapy
JP5284964B2 (ja) ５員複素環化合物
IL274340B1 (en) Mono- and di-amidine endo-exonuclease inhibitors and methods for inhibiting endo-exonuclease activity
RU2720180C2 (ru) Соединения, применяемые в лечении неопластических заболеваний

Legal Events

Date Code Title Description
PSEA Patent sealed